Boston Scientific Corp Stock Beneish M Score

BSX Stock  USD 90.66  0.09  0.1%   
This module uses fundamental data of Boston Scientific to approximate the value of its Beneish M Score. Boston Scientific M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Boston Scientific Piotroski F Score and Boston Scientific Altman Z Score analysis.
  
At this time, Boston Scientific's Short and Long Term Debt Total is fairly stable compared to the past year. Net Debt is likely to rise to about 9.1 B in 2024, whereas Short Term Debt is likely to drop slightly above 417.5 M in 2024. At this time, Boston Scientific's Net Income Per Share is fairly stable compared to the past year. Research And Ddevelopement To Revenue is likely to rise to 0.13 in 2024, whereas Price To Sales Ratio is likely to drop 4.58 in 2024.
At this time, it appears that Boston Scientific Corp is an unlikely manipulator. The earnings manipulation may begin if Boston Scientific's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Boston Scientific executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Boston Scientific's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.37
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

1.0

Focus
Asset Quality

1.18

Focus
Expense Coverage

1.0

Focus
Gross Margin Strengs

1.11

Focus
Accruals Factor

1.0

Focus
Depreciation Resistance

0.63

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

1.0

Focus

Boston Scientific Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Boston Scientific's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables2.3 B2.2 B
Sufficiently Up
Slightly volatile
Total Revenue15 B14.2 B
Sufficiently Up
Slightly volatile
Total Assets36.9 B35.1 B
Sufficiently Up
Slightly volatile
Total Current Assets3.3 B6.5 B
Way Down
Slightly volatile
Non Current Assets Total30.1 B28.6 B
Sufficiently Up
Slightly volatile
Property Plant Equipment1.7 B3.3 B
Way Down
Slightly volatile
Depreciation And Amortization1.3 B1.2 B
Sufficiently Up
Slightly volatile
Selling General Administrative5.2 BB
Sufficiently Up
Slightly volatile
Total Current Liabilities5.2 B4.9 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total6.2 B10.7 B
Way Down
Slightly volatile
Net Debt9.1 B8.6 B
Sufficiently Up
Slightly volatile
Short Term Debt417.5 M531 M
Significantly Down
Pretty Stable
Long Term Debt5.6 B8.6 B
Way Down
Slightly volatile
Total Cash From Operating Activities2.6 B2.5 B
Sufficiently Up
Slightly volatile
Long Term Investments458.7 M413 M
Significantly Up
Slightly volatile
Gross Profit Margin0.770.6949
Significantly Up
Slightly volatile

Boston Scientific Corp Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Boston Scientific's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Boston Scientific in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Boston Scientific's degree of accounting gimmicks and manipulations.

About Boston Scientific Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Other Operating Expenses

12.61 Billion

At this time, Boston Scientific's Other Operating Expenses is fairly stable compared to the past year.

Boston Scientific Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Boston Scientific. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables1.9B1.5B1.8B2.0B2.2B2.3B
Total Revenue10.7B9.9B11.9B12.7B14.2B15.0B
Total Assets30.6B30.8B32.2B32.5B35.1B36.9B
Total Current Assets4.7B6.7B6.3B5.8B6.5B3.3B
Net Debt10.1B7.8B7.5B8.4B8.6B9.1B
Short Term Debt1.4B13M261M20M531M417.5M
Long Term Debt8.6B9.1B8.8B8.9B8.6B5.6B
Operating Income1.5B1.0B2.0B1.6B2.3B2.5B
Investments(348M)(146M)15M56M(1.7B)(1.6B)

Boston Scientific ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.
Environmental
Governance
Social

About Boston Scientific Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.